This, however, will not be the first use of a PIKfyve inhibitor in clinical trials for the treatment of various diseases, including cancer (Sands et al., 2010; Krausz et al., 2012; Cai et al., 2013; Nelson et al., 2017). This evidence concerns the gene PIKFYVE and cancer.